Resumen de Stereotactic body radiotherapy for early‑stage non‑small cell lung cancer:: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Pilar Samper Ots, Carmen Vallejo Ocaña, Margarita Martín Martín, Francisco Javier Celada Álvarez, D. Farga Albiol, Piedad Almendros Blanco, Ana Hernández Machancoses, Mikel Rico Osés, S. Flamarique, Fabiola Romero Ruperto, C. Bueno, Enrique Amaya, L.L. Guerrero Gómez, Felipe Couñago Lorenzo, Pino Alcántara Carrió, J. C. Ruiz, José Luis Monroy Antón, P. Saez Bueno, Javier Luna Tirado, Mª del Mar Puertas, Assyatou Bobo Sow, I. Diaz de Cerio Martínez, N. Gascón Costoso, Carlos Ferrer Albiach
Purpose/objective(s) Stereotactic body radiotherapy (SBRT) has become the standard of care for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC) and for patients who refuse surgery. The aim of this study was to evaluate the effectiveness and safety of primary SBRT in patients with early-stage NSCLC.
Materials/methods Retrospective multicenter study of 397 patients (416 primary lung tumours) treated with SBRT at 18 centres in Spain. 83.2% were men. The median age was 74.4 years. In 94.4% of cases, the tumour was inoperable. The patho- logical report was available in 54.6% of cases. SPSS vs 22.0. was used to perform all statistical analyses.
Results Complete response was obtained in 53.6% of cases. Significant prognostic factors were standard CT planning (p = 0.014) and 4D cone beam CT (p = 0.000). Acute and chronic toxicity ≥ grade 3 was observed in 1.2% of cases. At a median follow-up of 30 months, local relapse was 9.6%, lymph node relapse 12.8%, distant metastasis 16.6%, and another lung tumour 11.5%. Complete response was the only significant prognostic factor for local relapse (p = 0.012) and distant metastasis (p = 0.001). The local relapse-free survival was 88.7%. The overall survival was 75.7%. The cancer-specific sur- vival was 92.7%. The disease-free survival was 78.7%.
Conclusion SBRT is an effective and well-tolerated treatment option for patients with early-stage lung cancer who are not suitable for surgery. The most important prognostic factor for local and distant recurrence was complete response, which in our sample depended on the type of CT planning and the IGRT technique.
